Hinge Health, Inc. is trading 4.5% up at $65.58 in pre-market after the company raised its financial outlook for the second quarter and full-year 2026, ahead of its inaugural Investor Day on June 10.
- Q2 2026 Guidance: Revenue is now expected to be between $200 million and $202 million, representing 45% year-over-year growth at the midpoint.
- Full-Year 2026 Guidance: Revenue guidance was increased to a range of $818 million to $824 million, up $20 million at the midpoint and reflecting 40% year-over-year growth.
- Analyst Action: Following the announcement, Stifel raised its price target on the stock to $79 from $67.